Tuesday May 14 | BioSpace
Stereotaxis, Inc. Reports First Quarter 2013 Financial Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! ST.
Stereotaxis (STXS) Announces Quarterly Earnings, Misses Expectations By $0.11 EPS
Stereotaxis released its earnings data on Monday. The company reported EPS for the quarter, missing the Thomson Reuters consensus estimate of by $0.11, StocKRatingsNetwork.com reports.
Stereotaxis: Here's What Investors Need to Know Before Earnings
Stereotaxis will report earnings after markets close on Monday, May 13th. Stereotaxis Inc.
St. Louis-based medical device maker Stereotaxis removed "interim" from Martin Stammer's title, and he'll now serve as chief financial officer, according to a recent filing with the Securities and Exchange Commission.
St. Louis-based medical device maker Stereotaxis removed "interim" from Martin Stammer 's title, and he'll now serve as chief financial officer, according to a recent filing with the Securities and Exchange Commission.